102 related articles for article (PubMed ID: 19187944)
1. Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis.
Pandit A; Vadnal J; Houston S; Freeman E; McDonough J
J Neurol Sci; 2009 Apr; 279(1-2):14-20. PubMed ID: 19187944
[TBL] [Abstract][Full Text] [Related]
2. Is nuclear respiratory factor 2 a master transcriptional coordinator for all ten nuclear-encoded cytochrome c oxidase subunits in neurons?
Ongwijitwat S; Wong-Riley MT
Gene; 2005 Oct; 360(1):65-77. PubMed ID: 16126350
[TBL] [Abstract][Full Text] [Related]
3. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
4. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis.
Bizzozero OA; DeJesus G; Callahan K; Pastuszyn A
J Neurosci Res; 2005 Sep; 81(5):687-95. PubMed ID: 16007681
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
6. Aberrant transcriptional regulatory network in T cells of multiple sclerosis.
Satoh J; Illes Z; Peterfalvi A; Tabunoki H; Rozsa C; Yamamura T
Neurosci Lett; 2007 Jul; 422(1):30-3. PubMed ID: 17629622
[TBL] [Abstract][Full Text] [Related]
7. Subchronic exposure to arsenic decreased Sdha expression in the brain of mice.
Hong Y; Piao F; Zhao Y; Li S; Wang Y; Liu P
Neurotoxicology; 2009 Jul; 30(4):538-43. PubMed ID: 19422848
[TBL] [Abstract][Full Text] [Related]
8. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients.
Dutta R; McDonough J; Chang A; Swamy L; Siu A; Kidd GJ; Rudick R; Mirnics K; Trapp BD
Brain; 2007 Oct; 130(Pt 10):2566-76. PubMed ID: 17898009
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis.
Thangarajh M; Masterman T; Rot U; Duvefelt K; Brynedal B; Karrenbauer VD; Hillert J
J Neuroimmunol; 2005 Oct; 167(1-2):210-4. PubMed ID: 16087247
[TBL] [Abstract][Full Text] [Related]
10. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
Lindberg RL; Achtnichts L; Hoffmann F; Kuhle J; Kappos L
J Neuroimmunol; 2008 Feb; 194(1-2):153-64. PubMed ID: 18178259
[TBL] [Abstract][Full Text] [Related]
11. Postmortem delay has minimal effect on brain RNA integrity.
Ervin JF; Heinzen EL; Cronin KD; Goldstein D; Szymanski MH; Burke JR; Welsh-Bohmer KA; Hulette CM
J Neuropathol Exp Neurol; 2007 Dec; 66(12):1093-9. PubMed ID: 18090918
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
[TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
14. The expression of NF-E2-related factor 2 in the rat brain after traumatic brain injury.
Yan W; Wang HD; Feng XM; Ding YS; Jin W; Tang K
J Trauma; 2009 May; 66(5):1431-5. PubMed ID: 19430250
[TBL] [Abstract][Full Text] [Related]
15. Aluminium-induced oxidative DNA damage recognition and cell-cycle disruption in different regions of rat brain.
Kumar V; Bal A; Gill KD
Toxicology; 2009 Oct; 264(3):137-44. PubMed ID: 19464335
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Dutta R; McDonough J; Yin X; Peterson J; Chang A; Torres T; Gudz T; Macklin WB; Lewis DA; Fox RJ; Rudick R; Mirnics K; Trapp BD
Ann Neurol; 2006 Mar; 59(3):478-89. PubMed ID: 16392116
[TBL] [Abstract][Full Text] [Related]
17. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
18. Multiple defects in the respiratory chain lead to the repression of genes encoding components of the respiratory chain and TCA cycle enzymes.
Bourges I; Mucchielli MH; Herbert CJ; Guiard B; Dujardin G; Meunier B
J Mol Biol; 2009 Apr; 387(5):1081-91. PubMed ID: 19245817
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling identifies a role for CHOP during inhibition of the mitochondrial respiratory chain.
Ishikawa F; Akimoto T; Yamamoto H; Araki Y; Yoshie T; Mori K; Hayashi H; Nose K; Shibanuma M
J Biochem; 2009 Jul; 146(1):123-32. PubMed ID: 19304788
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2).
Maruichi T; Fukami T; Nakajima M; Yokoi T
Biochem Pharmacol; 2010 Jan; 79(2):288-95. PubMed ID: 19715681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
